Key Takeaways
- • GMO's analysis of 700 leveraged buyouts reveals private equity portfolios are increasingly concentrated in risky, low-quality software firms, raising portfolio risk concerns for institutional investors.
- • Ben Inker's Investment Committee letter challenges the persistent belief in private equity performance persistence, questioning whether historical outperformance justifies current allocations and fee structures.
- • Private equity marks have remained artificially elevated during weak economic periods, creating a false sense of downside protection and obscuring true portfolio volatility for LPs.
- • GMO contends that years of strong private equity performance have erased institutional awareness of genuine downside risk in the asset class, particularly as economic conditions deteriorate.
- • The analysis suggests performance persistence in private equity—a core justification for institutional commitment—is eroding and should be re-evaluated by investment committees.
Summary
GMO's second-quarter 2026 quarterly letter, authored by co-founder Ben Inker and analyst John Pease, presents a critical examination of private equity portfolio construction and performance persistence at a time when institutional investors face mounting pressure to deliver returns in a low-yield, high-valuation environment.
The centerpiece of the analysis is GMO's study of 700 leveraged buyouts, which reveals a structural shift toward concentration in software and technology assets characterized as "risky, low-quality" holdings. This concentration pattern contradicts the diversification rationale that has historically justified private equity allocations within institutional portfolios. The research indicates that private equity portfolios have drifted from traditional industrial and business services holdings into software-heavy strategies, a shift that may amplify drawdown severity during economic downturns when software valuations typically compress alongside venture capital.
Inker's letter to the Investment Committee directly addresses what he terms "the persistent dream of performance persistence"—the core belief underpinning LP commitments to private equity vehicles. The letter questions whether historical outperformance, built on a foundation of strong decade-long returns and occasional stale pricing in private markets, justifies current allocations. GMO argues that institutional memory of private equity downside has been effectively erased by years of positive returns, leading committees to underestimate tail risks in their portfolios.
A critical observation in the analysis concerns valuation opacity in private markets. Years of strong performance, coupled with the practice of holding outdated marks during weak periods, have created what GMO describes as a "fugue"—a disconnect between perceived and actual portfolio risk. When broader economies suffer, equity downside typically follows, yet private portfolios have often insulated LPs from this reality through conservative marking practices. This dynamic obscures true volatility and has allowed institutional investors to maintain confidence in private equity as a diversifying asset class without confronting genuine drawdown scenarios.
The letter's underlying message is straightforward: as conventional asset allocation frameworks face headwinds—with the GMO commentary noting that "60/40 portfolios are not going to generate the returns that investors say they need"—institutions should scrutinize private equity's role critically rather than reflexively increasing allocations. The persistence of performance, on which the case for private equity rests, deserves renewed examination.
The centerpiece of the analysis is GMO's study of 700 leveraged buyouts, which reveals a structural shift toward concentration in software and technology assets characterized as "risky, low-quality" holdings. This concentration pattern contradicts the diversification rationale that has historically justified private equity allocations within institutional portfolios. The research indicates that private equity portfolios have drifted from traditional industrial and business services holdings into software-heavy strategies, a shift that may amplify drawdown severity during economic downturns when software valuations typically compress alongside venture capital.
Inker's letter to the Investment Committee directly addresses what he terms "the persistent dream of performance persistence"—the core belief underpinning LP commitments to private equity vehicles. The letter questions whether historical outperformance, built on a foundation of strong decade-long returns and occasional stale pricing in private markets, justifies current allocations. GMO argues that institutional memory of private equity downside has been effectively erased by years of positive returns, leading committees to underestimate tail risks in their portfolios.
A critical observation in the analysis concerns valuation opacity in private markets. Years of strong performance, coupled with the practice of holding outdated marks during weak periods, have created what GMO describes as a "fugue"—a disconnect between perceived and actual portfolio risk. When broader economies suffer, equity downside typically follows, yet private portfolios have often insulated LPs from this reality through conservative marking practices. This dynamic obscures true volatility and has allowed institutional investors to maintain confidence in private equity as a diversifying asset class without confronting genuine drawdown scenarios.
The letter's underlying message is straightforward: as conventional asset allocation frameworks face headwinds—with the GMO commentary noting that "60/40 portfolios are not going to generate the returns that investors say they need"—institutions should scrutinize private equity's role critically rather than reflexively increasing allocations. The persistence of performance, on which the case for private equity rests, deserves renewed examination.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.